← Open Payments lookup

VIRGINIA NIX: Open Payments

NPI 1033341201 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$548 in 28 payments from 11 companies in 2025. Trend: 2023 $288 · 2024 $522 · 2025 $548

Food & beverage: $548
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation8$148
Merck Sharp & Dohme LLC5$106
AstraZeneca Pharmaceuticals LP4$79
Eisai Inc.3$51
Genentech USA, Inc.2$44
Celgene Corporation1$28
Incyte Corporation1$24
PFIZER INC.1$19
SOBI, INC1$18
Genmab U.S., Inc.1$16

Products named: KEYTRUDA, IMFINZI, SCEMBLIX, Lenvima, KISQALI, REBLOZYL, LUTATHERA, JAKAFI.

Industry payments across AL — which companies pay providers there.